Abstract
Neuroblastoma and its benign differentiated counterpart, ganglioneuroma, are paediatric neuroblastic tumours arising in the sympathetic nervous system. Their broad spectrum of clinical virulence is mainly related to heterogeneous biologic background and tumour differentiation. Neuroblastic tumours synthesize various neuropeptides acting as neuromodulators. Previous studies suggested that galanin plays a role in sympathetic tissue where it could be involved in differentiation and development. We investigated the expression and distribution of galanin and its three known receptors (Gal-R1, Gal-R2, Gal-R3) in 19 samples of neuroblastic tumours tissue by immunohistochemistry, in situ hybridization and fluorescent-ligand binding. This study provides clear evidence for galanin and galanin receptor expression in human neuroblastic tumours. The messengers coding for galanin, Gal-R1 and -R3 were highly expressed in neuroblastoma and their amount dramatically decreased in ganglioneuroma. In contrast, Gal-R2 levels remained unchanged. Double labelling studies showed that galanin was mainly co-expressed with its receptors whatever the differentiation stage. In neuroblastic tumours, galanin might promote cell-survival or counteract neuronal differentiation through the different signalling pathways mediated by galanin receptors. Finally, our results suggest that galanin influences neuroblastoma growth and development as an autocrine/paracrine modulator. These findings suggest potential critical implications for galanin in neuroblastic tumours development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Albers AR, O'Dorisio MS, Balster DA, Caprara M, Gosh P, Chen F, Hoeger C, Rivier J, Wenger GD, O'Dorisio TM, Qualman SJ (2000) Somatostatin receptor gene expression in neuroblastoma. Regul Pept 88: 61–73
Barreto-Estrada JL, Medina-Vera L, De Jesus Escobar JM, Garcia-Arraras JE (1997) Development of galanin and enkephalin-like reactivities in the sympathoadrenal lineage of the avian embryo. In vivo and in vitro studies. Dev Neurosci 19: 328–336
Bartfai T, Hökfelt T, Langel U (1993) Galanin, a neuroendocrine peptide. Crit Rev Neurobiol 7: 229–274
Bjellerup P, Theodorsson E, Jornvall H, Kogner P (2000) Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours. Br J Cancer 83: 171–176
Borgstrom P, Hassan M, Wassberg E, Refai E, Jonsson C, Larsson SA, Jacobsson H, Kogner P (1999) The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo. Pediatr Res 46: 328–332
Bowman LC, Castleberry RP, Cantor A, Joshi V, Cohn SL, Smith EI, Yu A, Brodeur GM, Hayes FA, Look AT (1997) Genetic staging of unresectable or metastatic neuroblastoma in infants: A Pediatric Oncology Group Study. J Natl Cancer Inst 89: 373–380
Broberger C, Landry M, Wong H, Walsh J, Hökfelt T (1997) Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin and neuropeptide Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 66: 393–408
Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castleberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466–1477
Burazin TC, Larm JA, Ryan MC, Gundlach AL (2000) Galanin-R1 and –R2 receptor mRNA expression during the development of rat brain suggests differential subtype involvement in synaptic transmission and plasticity. Eur J Neuroscience 12: 2901–2917
Coze C, Hartmann O, Michon J, Frappaz D, Dusol F, Rubie H, Plouvier E, Leverger G, Bordigoni P, Behar C, Mechinaud F, Bergeron C, Plantaz D, Otten J, Zucker JM, Philip T, Bernard JL (1997) NB 87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology. J Clin Oncol 15: 3433–3440
Dagerlind Å, Friberg K, Bean A, Hökfelt T (1992) Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry. Histochemistry 98: 39–49
Del Fiacco M, Quartu M (1994) Somatostatin, galanin and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: immunohistochemistry, neuronal morphometry and colocalization with substance P. J Chem Neuroanat 7: 171–184
Eggert A, Ikegaki N, Liu X, Chou TT, Lee VM, Trojanowski JQ, Brodeur GM (2000) Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 13: 2043–2051
Garcia-Arraras JE, Torres-Avillan I (1999) Development expression of galanin-like immunoreactivity by members of the avian sympathoadrenal cell lineage. Cell Tissue Res 295: 33–41
Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF (1994) Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 91: 9780–9783
Heasley LE (2001) Autocrine and paracrine signaling through neuropeptide receptors in human cancer. Oncogene 20: 1563–1569
Holmes FE, Mahoney S, King VR, Bacon A, Kerr NC, Pachnis V, Curtis R, Priestley JV, Wynick D (2000) Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity. Proc Natl Acad Sci USA 97: 11563–11568
Hulting AL, Land T, Berthold M, Langel U, Hökfelt T, Bartfai T (1993) Galanin receptors from human pituitary tumours assayed with human galanin. Brain Res 625: 173–176
Invitti C, Giraldi FP, Dubini A, Moroni P, Losa M, Picoletti R, Cavagnini F (1999) Galanin is released by adrenocorticotropin-secreting pituitary adenomas in vivo and in vitro. J Clin Endocrinol Metab 84: 1351–1356
Kogner P (1995) Neuropeptides in neuroblastomas and ganglioneuroblastomas. Prog Brain Res 104: 325–338
Kolakowski L, O'Neill G, Howard A, Broussard SR, Sullivan KA, Feighner SD, Sawdargo M, Nguyen T, Kargman S, Shiao LL, Hreniuk DL, Tan CP, Evans J, Abramovitz M, Chateauneuf A, Coulombe N, Ng G, Johnson MP, Tharian A, Khoshbouei H, George SR, Smith RG, O'Dowd BF (1998) Molecular characterization and expression of cloned human galanin receptors Gal-R2 and Gal-R3. J Neurochem 71: 2239–2251
Landry M, Holmberg K, Zhang X, Hökfelt T (2000) Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry. Exp Neurol 162: 361–384
Le Moine C, Bloch B (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355: 418–427
Marinissen MJ, Gutkind JS (2001) G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22: 368–376
Marti E, Gibson SJ, Polak JM, Facer P, Springball DR, Aswegen GV, Aitchison M, Koltzenburg M (1987) Ontogeny of peptide- and amine-containing neurons in motor sensory, and autonomic regions of rat and human spinal cord, dorsal root ganglia, and rat skin. J Comp Neurol 266: 332–359
Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT, Brodeur GM, Gerbing RB, Reynolds CP (1999) Treatment of high-risk neuroblastoma with invasive chemotherapy, radiotherapy, autologous bone marrow transplantation and 13-cisretinoic acid. Children's Cancer group. N Engl J Med 341: 1165–1173
McKnight GL, Karlsen AE, Kowalyk S, Mathewes SL, Sheppard PO, O'Hara PJ, Taborsky GJ (1992) Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes 41: 82–87
Mellentin-Michelotti J, Evangelista LT, Swartzman EE, Miraglia SJ, Werner WE, Yuan PM (1999) Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. Anal Biochem 272: 182–190
Nakagawara A, Brodeur GM (1997) Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study. Eur J Cancer 33: 2050–2053
O'Meara G, Coumis U, Ma SY, Kehr J, Mahoney S, Bacon A, Allen SJ, Holmes F, Kahl U, Wang FH, Kearns IR, Ove-Ogren S, Dawbarn D, Mufson EJ, Davies C, Dawson G, Wynick D (2000) Galanin regulates the postnatal survival of a subset of basal forebrain cholinergic neurons. Proc Natl Acad Sci USA 97: 11569–11574
Rubie H, Hartmann O, Michon J, Frappaz D, Coze C, Chastagner P, Baranzelli MC, Plantaz D, Avet-Loiseau H, Benard J, Delattre O, Favrot M, Peyroulet MC, Thyss A, Perel Y, Bergeron C, Courbon-Collet B, Vannier JP, Lemerle J, Sommelet D (1997) N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the NB 90 study. Neuroblastoma Study Group of the Societe Française d'Oncologie Pediatrique. J Clin Oncol 15: 1171–1182
Sano T, Vrontakis ME, Kovacs K, Asa SL, Friesen HG (1991) Galanin immunoreactivity in neuro-endocrine tumors. Arch Pathol Lab Med 115: 926–929
Schmitz GG, Walter T, Seibl R, Kessler C (1991) Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Ann Biochem 192: 222–231
Sethi T, Langdon S, Smyth J, Rozengurt E (1992) Growth of small cell lung cancer cells: Stimulation by multiple neuropeptides and inhibition by broad spectrum antagonists in vitro and in vivo. Cancer Res 52: 2737–2742
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86: 349–363
Todd JF, Small CJ, Akinsanya KO, Stanley SA, Smith DM, Bloom SR (1998) Galanin is a paracrine inhibitor of gonadotroph function in the female rat. Endocrinology 139: 4222–4429
Tuechler C, Hametner R, Jones N, Jones R, Iismaa TP, Sperl W, Kofler B (1998) Galanin and galanin receptor expression in neuroblastoma. Ann NY Acad Sci 863: 438–441
Weiss WA, Aldape K, Mohabatra G, Feuerstein BG, Bishop JM (1997) Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16: 2985–2995
Xu ZQ, Shi TJ, Hökfelt T (1996) Expression of galanin and a galanin receptor in several sensory systems and bone anlage of rat embryos. Proc Natl Acad Sci USA 93: 14901–14905
Zigmond RE, Sun Y (1997) Regulation of neuropeptide expression in sympathetic neurons. Paracrine and retrograde influences. Ann N Y Acad Sci 814: 181–197
Acknowledgements
This work was partially supported by grants from the Direction de la Recherche Clinique du Centre Hospitalo-Universitaire de Bordeaux, the Centre National de la Recherche Scientifique (CNRS) and the Ligue Nationale contre le Cancer.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Perel, Y., Amrein, L., Dobremez, E. et al. Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. Br J Cancer 86, 117–122 (2002). https://doi.org/10.1038/sj.bjc.6600019
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600019
Keywords
This article is cited by
-
A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma
BMC Medical Genomics (2022)
-
Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
World Journal of Surgical Oncology (2022)
-
Effects of bilateral adrenalectomy on systemic kainate-induced activation of the nucleus of the solitary tract. Regulation of blood pressure and local neurotransmitters
Journal of Molecular Histology (2008)